IBDEI1E1 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23153,1,4,0)
 ;;=4^I35.1
 ;;^UTILITY(U,$J,358.3,23153,2)
 ;;=^5007175
 ;;^UTILITY(U,$J,358.3,23154,0)
 ;;=I35.2^^110^1098^12
 ;;^UTILITY(U,$J,358.3,23154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23154,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
 ;;^UTILITY(U,$J,358.3,23154,1,4,0)
 ;;=4^I35.2
 ;;^UTILITY(U,$J,358.3,23154,2)
 ;;=^5007176
 ;;^UTILITY(U,$J,358.3,23155,0)
 ;;=I35.9^^110^1098^9
 ;;^UTILITY(U,$J,358.3,23155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23155,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,23155,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,23155,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,23156,0)
 ;;=I42.7^^110^1098^3
 ;;^UTILITY(U,$J,358.3,23156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23156,1,3,0)
 ;;=3^Cardiomyopathy d/t Drug/External Agent
 ;;^UTILITY(U,$J,358.3,23156,1,4,0)
 ;;=4^I42.7
 ;;^UTILITY(U,$J,358.3,23156,2)
 ;;=^5007198
 ;;^UTILITY(U,$J,358.3,23157,0)
 ;;=I21.3^^110^1098^14
 ;;^UTILITY(U,$J,358.3,23157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23157,1,3,0)
 ;;=3^STEMI,Unspec Site
 ;;^UTILITY(U,$J,358.3,23157,1,4,0)
 ;;=4^I21.3
 ;;^UTILITY(U,$J,358.3,23157,2)
 ;;=^5007087
 ;;^UTILITY(U,$J,358.3,23158,0)
 ;;=I25.5^^110^1098^8
 ;;^UTILITY(U,$J,358.3,23158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23158,1,3,0)
 ;;=3^Ischemic Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,23158,1,4,0)
 ;;=4^I25.5
 ;;^UTILITY(U,$J,358.3,23158,2)
 ;;=^5007115
 ;;^UTILITY(U,$J,358.3,23159,0)
 ;;=I25.9^^110^1098^6
 ;;^UTILITY(U,$J,358.3,23159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23159,1,3,0)
 ;;=3^Chronic Ischemic Heart Disease,Unspec
 ;;^UTILITY(U,$J,358.3,23159,1,4,0)
 ;;=4^I25.9
 ;;^UTILITY(U,$J,358.3,23159,2)
 ;;=^5007144
 ;;^UTILITY(U,$J,358.3,23160,0)
 ;;=I25.10^^110^1098^2
 ;;^UTILITY(U,$J,358.3,23160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23160,1,3,0)
 ;;=3^Athscl Hrt Disease Native Coronary Artery w/o Ang Pctrs
 ;;^UTILITY(U,$J,358.3,23160,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,23160,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,23161,0)
 ;;=D64.9^^110^1098^1
 ;;^UTILITY(U,$J,358.3,23161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23161,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,23161,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,23161,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,23162,0)
 ;;=I42.9^^110^1098^4
 ;;^UTILITY(U,$J,358.3,23162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23162,1,3,0)
 ;;=3^Cardiomyopathy,Unspec
 ;;^UTILITY(U,$J,358.3,23162,1,4,0)
 ;;=4^I42.9
 ;;^UTILITY(U,$J,358.3,23162,2)
 ;;=^5007200
 ;;^UTILITY(U,$J,358.3,23163,0)
 ;;=I67.9^^110^1098^5
 ;;^UTILITY(U,$J,358.3,23163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23163,1,3,0)
 ;;=3^Cerebrovascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,23163,1,4,0)
 ;;=4^I67.9
 ;;^UTILITY(U,$J,358.3,23163,2)
 ;;=^5007389
 ;;^UTILITY(U,$J,358.3,23164,0)
 ;;=F04.^^110^1099^2
 ;;^UTILITY(U,$J,358.3,23164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23164,1,3,0)
 ;;=3^Amnestic Disorder d/t Physiological Condition
 ;;^UTILITY(U,$J,358.3,23164,1,4,0)
 ;;=4^F04.
 ;;^UTILITY(U,$J,358.3,23164,2)
 ;;=^5003051
 ;;^UTILITY(U,$J,358.3,23165,0)
 ;;=F05.^^110^1099^3
 ;;^UTILITY(U,$J,358.3,23165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23165,1,3,0)
 ;;=3^Delirium d/t Phsyiological Condition
 ;;^UTILITY(U,$J,358.3,23165,1,4,0)
 ;;=4^F05.
 ;;^UTILITY(U,$J,358.3,23165,2)
 ;;=^5003052
 ;;^UTILITY(U,$J,358.3,23166,0)
 ;;=F06.8^^110^1099^6
 ;;^UTILITY(U,$J,358.3,23166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23166,1,3,0)
 ;;=3^Mental Disorders d/t Physiological Condition
